Sanome
Andrew Creagh is a skilled professional in the field of artificial intelligence and machine learning, currently serving in an AI/ML role at Sanome since June 2023, while also holding positions as a Visiting Research Fellow and Postdoctoral Researcher at the University of Oxford since October 2020, focusing on clinical applications for digital health and digital biomarkers. Previous experience includes a Junior Research Fellow role at St Cross College, a Postdoctoral Fellow at GSK specializing in digital biomarkers, and a Doctoral Researcher at Roche within the PREDi initiative. Andrew's early career featured a Scientific Officer position at the Health Products Regulatory Authority and a Product Development Engineering Co-Op at Incereb Ltd. Educational qualifications encompass a DPhil in Clinical Machine Learning from the University of Oxford, an MAI in Biomedical Engineering, and a combined BA and BAI in Biomedical Engineering from Trinity College Dublin, alongside an M.A. from the University of Oxford.
This person is not in any teams
This person is not in any offices
Sanome
1 followers
Sanome is building the true Human Digital Twin – a real-time, clinically integrated view of every person’s health that is enabling health systems as they shift to a more proactive and preventative model of care. Through real-time analysis of clinical records – made possible through unique data access agreements with hospital partners and full read/write integration with leading EPR/EMR providers – Sanome is developing a pipeline of fully-regulated, explainable AI-enabled Clinical Decision Support tools (Class IIb Software-as-a-Medical Device). Embedded directly into clinical workflows and co-designed with clinical teams, our tools help clinicians to understand emerging risks earlier and make faster, more accurate decisions at scale.